The page is the record's research on the issuer — no analyst, no rating, no view. # ALLERGY THERAPEUTICS PLC (AIM: AGY) — research page As of 2026-11-06 · uk-cm-kg · record version 1 ## Identity and listing The issuer is ALLERGY THERAPEUTICS PLC, listed on AIM under ticker AGY, with ISIN GB00B02LCQ05 and LEI 213800PQ7AHK7KGVOE23. Its security type is Corporate and its segment is ASQ1. Its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted. ## The disclosure read The record holds 36 filings on 32 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 6 days. The median latency from the latest filing to the record date is 3 days, and the latest filing is dated 2026-11-03 and is of type halt_resume. The AIM peer median is 7.0 days for cadence and 4 days for latency, with a median of 33.5 filings. The sector peer median is 6.0 days for cadence and 4.0 days for latency, with a median of 42 filings, across 51 issuers in the sector. ## Auditor The auditor of record is BDO LLP. Its location is not on the record. Auditor changes are not on the record, as the market's record does not carry them. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as the index does not carry a lifecycle type for this register. The halt flag shows listed, not halted. ## Orderability For elective professional client, the outcome is ACM-200 and is determinable. For eligible counterparty, the outcome is ACM-200 and is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. The count is 0. ## Open research No openly published research notes were found. The count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth No issuer years are sealed. The market's vintage is not sealed, and no earliest sealed date is recorded. The live record began on 2026-09-11. The years 2021 through 2026 are sealed in the store but are not served as of a date, and the as-of door answers not_sealed. ## Sources 10 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange) - https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/AGY (identity.isin) - https://find-and-update.company-information.service.gov.uk/company/05141592 (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://www.londonstockexchange.com/stock/AGY/allergy-therapeutics-plc/company-page (identity.sector) - https://mcp.uk-cm-kg.ai/events/AIM/AGY (the disclosure lines) - https://marketsecurities.fca.org.uk/officiallist (the halt flag) - https://find-and-update.company-information.service.gov.uk/company/05141592/filing-history/MzQ5NjU2MTAxN2FkaXF6a2N4/document?format=pdf&download=0 (the auditor) - https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.uk-cm-kg.ai/record/AIM/AGY (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/uk/AIM/AGY · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp